USChina Trade Divergence Persists After TrumpXi Summit Japan Core Inflation Eases to Over FourYear Low Dimming Prospects for BOJ Rate Hike Pope Leo XIVs AI Encyclical Sparks Ethical Debate and Social Media Memes Nvidia Earnings Call in Focus as Market Awaits Commentary on China Chip Policy and Trump Tariffs UK Exports to US Tumble 25 Following Trumps Liberation Day Tariff Measures EU and Mexico Seal Updated Trade Deal to Diversify Supply Chains Amid Global Tensions ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress RPM Q1 2026 Earnings Stellar EPS Surprise of 5993 Drives Stock Higher BKKT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Revenue Uncertainty ONB Q1 2026 Earnings Slight EPS Miss Amidst Regional Banking Headwinds PAPL Q3 2025 Earnings EPS Surprises to the Upside Despite Stock Decline Beam Therapeutics BEAM Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Stellar V Capital Corp Unit SVCCU Holds Steady Key Support and Resistance Define the Next Move Relmada Therapeutics Inc RLMD Slips 236 as Stock Tests Key Support Levels Diginex Limited DGNX Surges 207 Key Levels and Trading Dynamics Neumora Therapeutics NMRA Stock Holds Steady at 185 as Key Support and Resistance Levels Tighten Crane Company CR Gains 248 as Shares Test Key Resistance Levels Tech IPOs Take a Backseat as Biotech and Healthcare Dominate US Public Listings AppLovin Shares Surge Amid Positive Market Sentiment Tesla Stock Consolidates in Tight Range as Recovery From Deep Lows Continues Microsoft in Talks to Supply Custom AI Chips to Anthropic Following 5 Billion Investment Companies Push Ahead with Prediction Market Investments Amid Regulatory Uncertainty Loop Capital Initiates Coverage on American Express With Buy Rating Names It Top Pick WATT Q1 2026 Earnings NarrowerthanExpected Loss Reflects Effective Cost Control Lionheart Holdings CUB Holds Steady at 1080 as Stock Trades Flat TYGO Q1 2026 Earnings Modest Beat on Bottom Line as Solar Enabler Navigates Industry Headwinds Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress CRVL Q1 2026 Earnings EPS of 061 Exceeds Expectation Stock Declines 269 FCNCN Q1 2026 Earnings Preferred Stock Investors Eye Strong EPS Beat as Bank Outperforms Expectations IN8bio Q1 2026 Earnings Narrowed Loss Beats Expectations as Development Pipeline Advances GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074 KORE Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Stock Reacts Modestly